Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
The agreement makes Endari available to patients represented by the Department of Defense, which include three million active military personnel and 9.4 million beneficiaries.
read more
Wednesday, February 06, 2019
EMMAC announced that Malta Enterprise has granted EMMAC a Letter of Intent under terms of the Production of Cannabis for Medicinal Use Act, 2018, Chapter 578 of the Laws of Malta.
read more
Friday, September 08, 2023
Eminence Biotechnology (Suzhou) Co., Ltd. announced that its state-of-the-art facility for the commercial production of cell culture media is now fully operational.
read more
Wednesday, August 17, 2022
Emery Pharma has expanded its lab. The extension of its new laboratory is streamlined to support research and development of large molecule drugs including, biologics, antibody-drug conjugates, biosimilars and others.
read more
Monday, February 25, 2019
Emergex Vaccines has successfully secured a state-of-the-art-research and development (R&D) facility at Milton Park, Oxfordshire.
read more
Emergent BioSolutions has entered into a formal partnership with the U.S. government to expedite development of a plasma-derived therapy for patients with COVID-19.
read more
Wednesday, August 09, 2023
Emergent BioSolutions announced it is reducing investment in and de-emphasizing focus on growth in its CDMO services business. As a result, Emergent is reducing operations at its Bayview facility in Baltimore, Maryland.
read more
PaxVax has entered into a definitive agreement to be acquired by Emergent BioSolutions.
read more
Emergent BioSolutions will collaborate with Novavax to support bringing into the clinic Novavax’s novel experimental vaccine candidate to protect against coronavirus disease (COVID-19).
read more
Wednesday, March 04, 2020
Axiom Real-Time Metrics announced its engagement with Emergent BioSolutions.
read more
Emergent BioSolutions has announced that its Center for Innovation in Advanced Developmentand Manufacturing (CIADM) has received a task order from the Biomedical Advanced Research and Development Authority (BARDA) valued at up to $21.9 million to ...
read more
Monday, September 24, 2018
ABEC announced the shipment of Emergent BioSolutions’ CSR dual purpose single-use systems for large scale 750L microbial fermentation and 500L mammalian cell culture.
read more
Monday, September 09, 2019
Emergent BioSolutions announced a contract award by the HHS over 10 years for the continued supply of ACAM2000® into the U.S. Strategic National Stockpile.
read more
Tuesday, September 19, 2017
Emergent BioSolutions has been awarded a contract valued at approximately $63 million by the BARDA to develop an antidote spray device for the treatment of known or suspected acute cyanide poisoning.
read more
Emergent BioSolutions has signed an indefinite-delivery, IDIQ contract with the Department of State to establish a long-term supply chain for medical countermeasures that address chemical warfare agents.
read more